Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G (2018) Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin Cancer Biol 53:265–281. https://doi.org/10.1016/j.semcancer.2018.10.002
Article CAS PubMed Google Scholar
Apte SS, Parks WC (2015) Metalloproteinases: a parade of functions in matrix biology and an outlook for the future. Matrix Biol 44–46:1–6. https://doi.org/10.1016/j.matbio.2015.04.005
Article CAS PubMed Google Scholar
Bjornland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH (1998) Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells. Oncol Res 10:255–262
Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N (2020) 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci 111:3142–3154. https://doi.org/10.1111/cas.14532
Article CAS PubMed PubMed Central Google Scholar
Blondy S, Talbot H, Saada S, Christou N, Battu S, Pannequin J, Jauberteau MO, Lalloué F, Verdier M, Mathonnet M et al (2021) Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer. J Cell Mol Med 25:47–60. https://doi.org/10.1111/jcmm.15752
Article CAS PubMed Google Scholar
Cabrero-de Las Heras S, Martínez-Balibrea E (2018) CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. World J Gastroenterol 24:4738–4749. https://doi.org/10.3748/wjg.v24.i42.4738
Article CAS PubMed PubMed Central Google Scholar
Chirco R, Liu XW, Jung KK, Kim HR (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25:99–113. https://doi.org/10.1007/s10555-006-7893-x
Article CAS PubMed Google Scholar
Das V, Kalita J, Pal M (2017) Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges. Biomed Pharmacother 87:8–19. https://doi.org/10.1016/j.biopha.2016.12.064
Article CAS PubMed Google Scholar
Du C, Huang D, Peng Y, Yao Y, Zhao Y, Yang Y, Wang H, Cao L, Zhu WG, Gu J (2017) 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer. Cancer Lett 400:183–193. https://doi.org/10.1016/j.canlet.2017.04.033
Article CAS PubMed Google Scholar
Escalona RM, Chan E, Kannourakis G, Findlay JK, Ahmed N (2018) The many facets of metzincins and their endogenous inhibitors: perspectives on ovarian cancer progression. Int J Mol Sci. https://doi.org/10.3390/ijms19020450
Article PubMed PubMed Central Google Scholar
Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, Dimmler A, Dorlaque L, Hohenberger W, Hahn EG et al (2009) Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases. Anticancer Res 29:67–74
Groblewska M, Mroczko B, Gryko M, Pryczynicz A, Guzinska-Ustymowicz K, Kedra B, Kemona A, Szmitkowski M (2014) Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients. Tumour Biol 35:3793–3802. https://doi.org/10.1007/s13277-013-1502-8
Article CAS PubMed Google Scholar
Lawrence W Jr, Terz JJ, Horsley S 3rd, Donaldson M, Lovett WL, Brown PW, Ruffner BW, Regelson W (1975) Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg 181:616–623. https://doi.org/10.1097/00000658-197505000-00016
Article PubMed PubMed Central Google Scholar
Liu T, Wang X, Hu W, Fang Z, Jin Y, Fang X, Miao QR (2019) Epigenetically raise PCAF increases the resistance of colorectal cancer to 5-fluorouracil. Neoplasia 21:557–570. https://doi.org/10.1016/j.neo.2019.03.011
Article CAS PubMed PubMed Central Google Scholar
Marjaneh RM, Khazaei M, Ferns GA, Avan A, Aghaee-Bakhtiari SH (2019) The role of microRNAs in 5-FU resistance of colorectal cancer: possible mechanisms. J Cell Physiol 234:2306–2316. https://doi.org/10.1002/jcp.27221
Article CAS PubMed Google Scholar
Na D, Chae J, Cho SY, Kang W, Lee A, Min S, Kang J, Kim MJ, Choi J, Lee W et al (2021) Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts. Nat Commun 12:4840. https://doi.org/10.1038/s41467-021-25122-4
Article CAS PubMed PubMed Central Google Scholar
Nishimoto S, Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782–786. https://doi.org/10.1038/sj.embor.7400755
Article CAS PubMed PubMed Central Google Scholar
Park KS, Kim SJ, Kim KH, Kim JC (2011) Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 26:391–397. https://doi.org/10.1111/j.1440-1746.2010.06504.x
Article CAS PubMed Google Scholar
Peeney D, Jensen SM, Castro NP, Kumar S, Noonan S, Handler C, Kuznetsov A, Shih J, Tran AD, Salomon DS et al (2020) TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer. Carcinogenesis 41:313–325. https://doi.org/10.1093/carcin/bgz172
Article CAS PubMed Google Scholar
Propper DJ, Balkwill FR (2022) Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 19:237–253. https://doi.org/10.1038/s41571-021-00588-9
Article CAS PubMed Google Scholar
Shen Q, Lee ES, Pitts RL, Wu MH, Yuan SY (2010) Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res 8:939–951. https://doi.org/10.1158/1541-7786.Mcr-09-0523
Article CAS PubMed PubMed Central Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics 2021. Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654
Tang YA, Chen YF, Bao Y, Mahara S, Yatim S, Oguz G, Lee PL, Feng M, Cai Y, Tan EY et al (2018) Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer. Proc Natl Acad Sci USA 115:E5990-e5999. https://doi.org/10.1073/pnas.1801348115
Article CAS PubMed PubMed Central Google Scholar
Tavakoli F, Jahanban-Esfahlan R, Seidi K, Jabbari M, Behzadi R, Pilehvar-Soltanahmadi Y, Zarghami N (2018) Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif Cells Nanomed Biotechnol 46:75–86. https://doi.org/10.1080/21691401.2018.1452021
Article CAS PubMed Google Scholar
Ushigome M, Shimada H, Miura Y, Yoshida K, Kaneko T, Koda T, Nagashima Y, Suzuki T, Kagami S, Funahashi K (2020) Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA. Int J Clin Oncol 25:622–632. https://doi.org/10.1007/s10147-019-01597-6
Article CAS PubMed Google Scholar
Waleh NS, Murphy BJ, Zaveri NT (2010) Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179. Cancer Lett 289:111–118. https://doi.org/10.1016/j.canlet.2009.08.006
Article CAS PubMed Google Scholar
Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, Liu S, Li A, He Z, Liu J et al (2019) Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. J Immunother Cancer 7:215. https://doi.org/10.1186/s40425-019-0701-2
Article PubMed PubMed Central Google Scholar
Wasserman I, Lee LH, Ogino S, Marco MR, Wu C, Chen X, Datta J, Sadot E, Szeglin B, Guillem JG et al (2019) SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance. Clin Cancer Res 25:1948–1956. https://doi.org/10.1158/1078-0432.Ccr-18-1726
Article CAS PubMed Google Scholar
Woolston A, Khan K, Spain G, Barber LJ, Griffiths B, Gonzalez-Exposito R, Hornsteiner L, Punta M, Patil Y, Newey A et al (2019) Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during Anti-EGFR treatment in colorectal cancer. Cancer Cell 36:35-50.e39. https://doi.org/10.1016/j.ccell.2019.05.013
Article CAS PubMed PubMed Central Google Scholar
Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP, Shun CT, Chen GH, Huang SP, Lin JT (2007) Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer 43:799–808. https://doi.org/10.1016/j.ejca.2006.10.022
Article CAS PubMed Google Scholar
Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, Zhang J, Qin Y, Qi X, Zhou L et al (2017) The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res 23:7375–7387. https://doi.org/10.1158/1078-0432.Ccr-17-1283
Article CAS PubMed Google Scholar
Zhang Q, Liu RX, Chan KW, Hu J, Zhang J, Wei L, Tan H, Yang X, Liu H (2019) Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells. J Exp Clin Cancer Res 38:320. https://doi.org/10.1186/s13046-019-1314-9
Article CAS PubMed PubMed Central Google Scholar
Zhang G, Luo X, Zhang W, Chen E, Xu J, Wang F, Cao G, Ju Z, Jin D, Huang X et al (2020) CXCL-13 regulates resistance to 5-fluorouracil in colorectal cancer. Cancer Res Treat 52:622–633. https://doi.org/10.4143/crt.2019.593
留言 (0)